Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Calling All Blood Donors …Even Older Drugs Are Getting Steep Price Hikes, Study FindsAs Medical Marketing Soars, Is Regulation Needed?Radiation Doses From CT Scans Vary WidelyU.S. Leads Health Care Spending Among Richer Nations, But Gets LessIs Your State a Hotspot for Obesity-Linked Cancers?Health Tip: Choose the Right DoctorFDA Warns Companies on Dangerous, Unapproved Stem Cell TreatmentsMore U.S. Kids Dying From Guns, Car AccidentsRoad Rules on Smartphone Use Are Saving Bikers' Lives, TooAHA: Should Pacemakers, Defibrillators Be Recycled -- and Reused in Others?California Farm Tied to E. coli Outbreak Expands Recall Beyond Romaine LettuceHealth Tip: Use Medical Devices SafelyCalifornia Farm Implicated in Outbreak of E. coli Tied to Romaine LettuceFentanyl Now the No. 1 Opioid OD KillerHospitalizations Rising Among the HomelessElectronic Health Records Bogging Docs DownMore Are Seeking Mental Health Care, But Not Always Those Who Need It MostMillions of Americans Still Breathing Secondhand Smoke: ReportNew Approach to Opioid Crisis: Supervised Heroin Injection Programs?Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollAs Gun Violence Grows, U.S. Life Expectancy DropsMost Americans Lie to Their DoctorsOpioid Crisis, Suicides Driving Decline in U.S. Life Expectancy: CDCWant to Learn CPR? Try an Automated KioskHealth Surrogates Often in Dark About Loved One's WishesRestaurant 'Health Grade' Posters Could Mean Safer DiningSmoking Bans Might Help Nonsmokers' Blood PressureWarmer Winters, More Violent Crimes?Are Food Additives Good or Bad? Consumer Views VaryDrug Studies in Children Often Go Unfinished: StudyFDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol CigarettesAgeism Costs Billions in Health Care DollarsAmerica Is Worried About Antibiotic ResistanceRed Cross Issues Urgent Call for Blood Ahead of the HolidaysUnder Pressure, Juul Withdraws Most Flavored E-Cigs From MarketMany Drugstores Won't Dispense Opioid Antidote as RequiredNew Cholesterol Guidelines Focus on Personalized ApproachAHA: Defibrillators Can Help Kids Survive Cardiac Arrest, TooFDA Will Ban Many Flavored E-CigarettesU.S. Smoking Rates Hit Record LowOnly a Quarter of Opioid Painkillers Taken After Most SurgeriesHome Health-Care Tests: Proceed With CautionFDA Takes on Flatulent CowsWhy Bystanders Are Less Likely to Give CPR to WomenCellphone Radiation Tied to Upped Odds for Cancer -- in RatsHealth Tip: FDA Discusses Possible Risks of Bodybuilding ProductsU.S. Hospitals Making Headway Against InfectionsAfter Mass Shootings, Blood Donations Can Go UnusedLead in Hair Dyes Must Go: FDA
Questions and AnswersLinksBook Reviews
Related Topics

2018 Immunization Schedule Issued for U.S. Children


HealthDay News
Updated: Feb 6th 2018

new article illustration

TUESDAY, Feb. 6, 2018 (HealthDay News) -- The recommended childhood and adolescent immunization schedule for the United States has been issued for 2018 and published online Feb. 6 in Pediatrics.

Carrie L. Byington, M.D., from the American Academy of Pediatrics Committee on Infectious Diseases, and colleagues present the recommended childhood and adolescent immunization schedules for 2018, which have been revised to reflect current recommendations for vaccine use.

The researchers note that there have been no changes made to the immunization schedule. Two changes have been made to the catch-up immunization schedule: the rotavirus vaccine row has been modified to include the maximum ages for the first and last dose of the series. In addition, the polio vaccine rows clarify the schedule for children aged 4 years or older. Certain changes have been made to footnotes, including additional information regarding the timing of the birth dose of hepatitis B vaccine for infants with a birth weight of <2,000 grams. MenHibrix (bivalent meningococcal conjugate vaccine and Haemophilus influenzae type b conjugate vaccine) has been removed as it is no longer commercially available. The live attenuated influenza vaccine is not recommended for the 2017 to 2018 influenza season. Additionally, guidance is offered for a third dose of a mumps-containing vaccine in case of a mumps outbreak.

"The schedules are revised annually to reflect current recommendations for the use of vaccines licensed by the U.S. Food and Drug Administration," the authors write.

Abstract/Full Text